March 26, 2020 / 1:10 PM / 11 days ago

BRIEF-Inovio Reports Positive Interim Phase 2 VGX-3100 Results In Patients With HPV-Associated Anal Dysplasia

March 26 (Reuters) - Inovio Pharmaceuticals Inc:

* INOVIO REPORTS POSITIVE INTERIM PHASE 2 VGX-3100 RESULTS IN PATIENTS WITH HPV-ASSOCIATED ANAL DYSPLASIA

* INOVIO- VGX-3100 DNA CLEARED HIGH-RISK HPV 16/18-ASSOCIATED PRECANCEROUS LESIONS IN 50% PATIENTS, REDUCED NUMBER OF LESIONS IN 75% PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below